Navigation Links
Research breakthrough paves the way for understanding serious diseases
Date:5/21/2014

A few years ago researchers described a Turkish family whose family members moved around on all fours. It turned out that they lacked the sense of equilibrium. This was caused by the rare neurological disease CAMRQ, which is the result of a mutation in the lipid pump in the cells. On the other hand, it was not known why the genetic error had such serious consequences.

The discovery provided inspiration for a Danish study of the mechanism for the vital lipid pump function, the so-called flippase, which transports lipids in the membrane that surrounds every single cell in the body. Researchers from Aarhus University have now presented a hypothesis that can explain how the flippase functions - and they have thus found the answer to a basic research question that has preoccupied researchers for years. The study has just been published in the recognised scientific journal PNAS.

Fundamental question for researchers around the world

14 different types of flippases are found in the cells. In collaboration with colleagues from Switzerland and Canada, the Danish researchers have put forward a model for how the transfer of lipid molecules takes place between the two layers in the cell membrane. The researchers created the model by mimicking the mutations from the Turkish family in the laboratory on one of the flippases - the so-called ATP8A2 - and then using computer simulations to study the structural changes of the flippase.

"With the model we have found a possible answer to the question known as 'the giant substrate problem.' It has not previously been possible to explain how a relatively small protein could transport large lipid molecules in the membrane. This fundamental question has occupied researchers around the world since the existence and size of the flippase protein became known. With the new knowledge we can understand how the mutation interferes with the lipid transport mechanism and thus, in this way, triggers disease," says postdoc Anna Lindelv Vestergaard, who is one of the researchers behind the project.

Research based on Danish Nobel Prize research

The study is based on the research tradition that Nobel Prize winner Jens Christian Skou laid the groundwork for when he became the first person to discover a pump function in the cells in the 1950s, the so-called sodium potassium pump.

The flippase and the sodium potassium pump belong to a group of a total of 36 different pump proteins that are found in the cell membranes in the body's cells. The pumps are vital and genetic defects in flippases contribute - in addition to the Turkish family's illness - to the deadly Byler's disease of the liver, involuntary childlessness and neurological diseases such as e.g. Alzheimer's disease.

"14 out of the 36 pumps in the cells are flippases. For that reason alone there is every reason to believe that they play an important role. Genetic errors in the flippases are probably the cause of many more diseases than we currently recognise. The basic scientific understanding is the first step. In the long term it can lead to us becoming better to diagnose and treat diseases that are caused by errors in a flippase," says postdoc Anna Lindelv Vestergaard, before continuing:

"The new knowledge can also be used for the development of new drugs as the flippases can also transport lipid-soluble medicines. Once we know how the medicine can get into the cell, it can be designed so that the treatment is more carefully targeted and effective."

Important step towards greater knowledge

The flippases ensure that there is asymmetry between the two lipid layers in the cell membrane, so that the membranes bend, which is necessary so that the cells can divide or fuse. This also means that the flippases are of significance during e.g. embryo development, fertilisation and the excretion of hormones from the cells into the blood.

"We surmise that the basic mechanism which we have discovered is universal for all flippases in humans and animals. So this is the first step towards far greater knowledge than we have today," says Professor Jens Peter Andersen, who has headed the study in collaboration with Anna Lindelv Vestergaard.


'/>"/>

Contact: Jens Peter Andersen
jpa@fi.au.dk
45-20-43-43-62
Aarhus University
Source:Eurekalert  

Related biology news :

1. NHAES researchers receive $482,500 grant to study nitrogen loss in soils
2. Researchers test whether Red Queen hypothesis makes species resilient
3. Compound reverses symptoms of Alzheimers disease in mice, SLU research shows
4. Nine young scientists awarded by the Genetics Society of America for fruit fly research
5. NIH researchers discover key factor in early auditory system development
6. DFG establishes 13 new research training groups
7. New research shows humans have more impact on tropical nitrogen levels
8. Scripps Research Institute chemists discover structure of cancer drug candidate
9. Google, YouTube, iPhones, Affordable Care Act featured in new research for role in hypertension
10. Eskitis links with European life science researchers
11. $31 million gift will fund early stage UW research by high-tech entrepreneurs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Research breakthrough paves the way for understanding serious diseases
(Date:2/26/2017)... , Feb. 25, 2017  Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... Recidivism and Reentry. "Too often, too ... prisons and county jails are trying to tackle ... inmates and friends and family members. While significant steps ...
(Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017 ... Family of Companies (Avamere Health Services, Infinity Rehab, Signature ... research study that will apply the power of IBM ... living and health centers. By analyzing data streaming from ... insights into physical and environmental conditions, and obtain deeper ...
(Date:2/14/2017)... Feb. 14, 2017  Wake Forest Baptist Medical Center ... new chief executive officer (CEO). Freischlag joins the medical ... D. McConnell , M.D., who last year announced that ... Medical Center, after leading it since 2008.   ... of Wake Forest Baptist,s academic health system, which includes ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... , March 23, 2017  Northwest Biotherapeutics ... DCVax® personalized immune therapies for solid tumor cancers, ... $7.5 million financing it announced last Friday, March ... to several institutional investors securities totaling 28,843,692 shares, ... share, and 10,000,000 shares of Class C Warrants ...
(Date:3/23/2017)... 23, 2017 Kineta, Inc., a biotechnology ... therapies in immuno-oncology, today announced the discovery and ... compounds that activate interferon response factor 3 (IRF3) ... immune-mediated tumor regression in a murine colon carcinoma ... demonstrated complete tumor regression to initial drug treatment ...
(Date:3/23/2017)... New Orleans, La. (PRWEB) , ... March 23, ... ... of real-time, industrial monitoring solutions, today announced the hire of Dr. Sigmund “Sig” ... for APMT customer applications, strategic partnerships and joint development activities. , “Dr. Floyd’s ...
(Date:3/22/2017)... March 22, 2017 Good Start Genetics, a ... eclipsed the 130 million covered lives mark through its ... Texas . With newly signed contracts ... to enjoy strong payor acceptance based on the quality ... and genetic counseling, its industry-leading customer care and support ...
Breaking Biology Technology: